Antiproliferative Agents

Antiproliferative Agents is a class of immunosuppressive drugs that inhibit lymphocyte proliferation by interfering with DNA synthesis or cell cycle progression, thereby preventing T-cell and B-cell expansion in response to alloantigen stimulation following kidney transplantation.

10.6K

Publications

507.3K

Citations

52.4K

Authors

6.5K

Institutions

Publications per year

2017–2026

3.3K

Variants

Antiproliferatives

Authors

52.4K

  1. EH
    Ernest Hamel

    National Cancer Institute, United States

    44 publications · 2.5K citations

    29

    h-index

  2. JW
    Joanna Wietrzyk

    Ludwik Hirszfeld Institute of Immunology and Experimental Therapy, Poland

    79 publications · 2.4K citations

    28

    h-index

  3. IZ
    István Zupkó

    University of Szeged, Hungary

    59 publications · 2K citations

    28

    h-index

  4. IO
    Ingo Ott

    Technische Universität Braunschweig, Germany

    32 publications · 2.7K citations

    27

    h-index

  5. JE
    João Ernesto de Carvalho

    Universidade Estadual de Campinas (UNICAMP), Brazil

    51 publications · 2K citations

    27

    h-index

1–5 of 52.4K

Venues

  1. Journal of Medicinal Chemistry

    613 publications · 41.3K citations

    103

    h-index

  2. PubMed

    Repository · 745 publications · 43.5K citations

    100

    h-index

  3. Molecular Cancer Therapeutics

    MCT · 155 publications · 12.9K citations

    67

    h-index

  4. European Journal of Medicinal Chemistry

    296 publications · 11.9K citations

    58

    h-index

  5. Cancer Research

    102 publications · 13.3K citations

    57

    h-index

1–5